Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105119389 | 10511938 | 9 | F | 20130913 | 20160802 | 20141010 | 20160805 | EXP | PHHY2014BR130052 | NOVARTIS | 39.92 | YR | F | Y | 66.00000 | KG | 20160806 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105119389 | 10511938 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 1 DF OF 30 MG, QMO (1 INJECTION EVERY 30 DAYS) | 21008 | 1 | DF | VIAL | /month | ||||||
| 105119389 | 10511938 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 1 DF OF 10 MG, QD | S0003D/RA0840A | 0 | 1 | DF | TABLET | QD | |||||
| 105119389 | 10511938 | 3 | SS | CALCIO | CALCIUM | 1 | Intravenous (not otherwise specified) | UNK, QMO | 0 | /month | |||||||||
| 105119389 | 10511938 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 1 DF OF 40 MG, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105119389 | 10511938 | 1 | Neuroendocrine tumour |
| 105119389 | 10511938 | 2 | Neuroendocrine carcinoma metastatic |
| 105119389 | 10511938 | 3 | Supplementation therapy |
| 105119389 | 10511938 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105119389 | 10511938 | DE |
| 105119389 | 10511938 | HO |
| 105119389 | 10511938 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105119389 | 10511938 | Anaemia | |
| 105119389 | 10511938 | Aphthous ulcer | |
| 105119389 | 10511938 | Bone pain | |
| 105119389 | 10511938 | Carcinoid heart disease | |
| 105119389 | 10511938 | Cough | |
| 105119389 | 10511938 | Diabetes mellitus | |
| 105119389 | 10511938 | Diarrhoea | |
| 105119389 | 10511938 | Erythema | |
| 105119389 | 10511938 | Haemorrhage | |
| 105119389 | 10511938 | Hypersensitivity | |
| 105119389 | 10511938 | Injection site pain | |
| 105119389 | 10511938 | Injection site swelling | |
| 105119389 | 10511938 | Malaise | |
| 105119389 | 10511938 | Malignant neoplasm progression | |
| 105119389 | 10511938 | Mass | |
| 105119389 | 10511938 | Metastasis | |
| 105119389 | 10511938 | Muscle spasms | |
| 105119389 | 10511938 | Oral discomfort | |
| 105119389 | 10511938 | Pleural effusion | |
| 105119389 | 10511938 | Renal failure | |
| 105119389 | 10511938 | Throat irritation | |
| 105119389 | 10511938 | Torticollis | |
| 105119389 | 10511938 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105119389 | 10511938 | 1 | 20130913 | 0 | ||
| 105119389 | 10511938 | 2 | 201404 | 0 | ||
| 105119389 | 10511938 | 4 | 201510 | 0 |